GlassScriptPhysician profile
Matthew B Hendrich
NPI 1528220639
$40,786.62
in general payments reported to CMS, 2019-2025
25 companies · $11K in 2025
The $11K reported for 2025 was more than what 91% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,247 · 2020: $1,396 · 2021: $554 · 2022: $8,204 · 2023: $7,060 · 2024: $10K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,243 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,350 · Consulting Fee: $5,250 · Travel and Lodging: $2,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,243.22 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,350.00 |
| Consulting Fee | $5,250.00 |
| Travel and Lodging | $2,242.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $21,152.20 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $8,432.23 | 2019-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Boston Scientific Corporation | $8,225.34 | 2021-2025 | Enroute Transcarotid Neuroprotection System, General - Therapies, General - Vascular Intervention |
| W. L. Gore & Associates, INC. | $988.86 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis With Heparin |
| Cvrx, INC. | $449.14 | 2022-2025 | Barostim Neo System |
| Haemonetics Corporation | $252.19 | 2024-2025 | Teg6s Hemostasis System |
| Abbott Laboratories | $244.23 | 2023-2025 | Esprit, Aveir, Mitraclip |
| Cook Medical LLC | $171.45 | 2023-2025 | Zilver Ptx, Cook, Zenith |
| Medtronic, INC. | $152.52 | 2021-2024 | Endurant Iis |
| Stryker Corporation | $115.31 | 2025 | Inthrill Thrombectomy Catheter, Artix Mt, Flowtriever Catheter, S |
| Ekos Corporation | $87.42 | 2019 | |
| Baxter Healthcare | $80.00 | 2019 | |
| Getinge USA Sales, LLC | $76.91 | 2020-2022 | |
| Lemaitre Vascular, INC. | $70.25 | 2021-2023 | Restoreflow |
| Angiodynamics, INC. | $68.14 | 2025 | Auryon Laser System 100-120 Vac |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $43.53 | 2019-2020 | |
| Edwards Lifesciences Corporation | $32.96 | 2025 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $25.39 | 2021 | |
| Abiomed | $20.40 | 2025 | |
| Portola Pharmaceuticals, LLC | $20.36 | 2019 | |
| Surmodics, INC. | $19.67 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
| Merck Sharp & Dohme LLC | $16.95 | 2023 | Bridion |
| Inari Medical, INC. | $14.66 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pacira Pharmaceuticals Incorporated | $13.92 | 2019 | |
| Irhythm Technologies, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hendrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.